Cargando…

Dual‐specificity tyrosine‐regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer

Colorectal cancer is a common cancer and a leading cause of cancer‐related death worldwide. The liver is a dominant metastatic site for patients with colorectal cancer. Molecular mechanisms that allow colorectal cancer cells to form liver metastases are largely unknown. Activation of epithelial–mese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Daisuke, Yogosawa, Satomi, Mimoto, Rei, Hirooka, Shinichi, Horiuchi, Takashi, Eto, Ken, Yanaga, Katsuhiko, Yoshida, Kiyotsugu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543514/ https://www.ncbi.nlm.nih.gov/pubmed/28502078 http://dx.doi.org/10.1111/cas.13280

Ejemplares similares

Downregulation of dual‐specificity tyrosine‐regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin‐dependent kinase 14 expression in breast cancer
por: Imawari, Yoshimi, et al.
Publicado: (2018)

Tumor suppressive role for kinases phosphorylating p53 in DNA damage‐induced apoptosis
por: Yogosawa, Satomi, et al.
Publicado: (2018)

Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells
por: Mimoto, Rei, et al.
Publicado: (2019)

Enforced dual‐specificity tyrosine‐regulated kinase 2 expression by adenovirus‐mediated gene transfer inhibits tumor growth and metastasis of colorectal cancer
por: Imaizumi, Yuta, et al.
Publicado: (2022)

Downregulation of CD24 suppresses bone metastasis of lung cancer
por: Okabe, Hinako, et al.
Publicado: (2017)

The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis
por: Yoshida, Saishu, et al.
Publicado: (2020)

Roles of activin receptor-like kinase 7 signaling and its target, peroxisome proliferator-activated receptor γ, in lean and obese adipocytes
por: Yogosawa, Satomi, et al.
Publicado: (2013)

Mice lacking DYRK2 exhibit congenital malformations with lung hypoplasia and altered Foxf1 expression gradient
por: Yogosawa, Satomi, et al.
Publicado: (2021)

Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras
por: Kamioka, Hiroshi, et al.
Publicado: (2023)

Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells
por: Sugano, Hiroshi, et al.
Publicado: (2018)

Correction: Hiroshi Sugano et al. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers 2018, 10, 386
por: Sugano, Hiroshi, et al.
Publicado: (2019)

Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα
por: Yogosawa, Satomi, et al.
Publicado: (2013)

Identification of CMTM7 as a Transmembrane Linker of BLNK and the B-Cell Receptor
por: Miyazaki, Atsuko, et al.
Publicado: (2012)

Mesothelial cyst with endometriosis mimicking a Nuck cyst
por: Uno, Yoshiko, et al.
Publicado: (2014)

Laparoscopic surgical challenge for T4a colon cancer
por: Hojo, Seishi, et al.
Publicado: (2017)

Laparoscopy-Assisted Repair for Intersigmoid Hernia
por: Nakaseko, Yuichi, et al.
Publicado: (2020)

Inhibition of protein kinase C delta leads to cellular senescence to induce anti‐tumor effects in colorectal cancer
por: Shimoyama, Yuya, et al.
Publicado: (2023)

PKCδ deficiency inhibits fetal development and is associated with heart elastic fiber hyperplasia and lung inflammation in adult PKCδ knockout mice
por: Niino, Yuko S., et al.
Publicado: (2021)

FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2
por: Jiménez-Izquierdo, Rafael, et al.
Publicado: (2023)

Multiple subcellular localizations and functions of protein kinase Cδ in liver cancer
por: Yamada, Kohji, et al.
Publicado: (2022)

Complete remission with tyrosine kinase inhibitors in renal cell carcinoma
por: Wada, Yoshihiro, et al.
Publicado: (2012)

Extended-Synaptotagmin 1 Enhances Liver Cancer Progression Mediated by the Unconventional Secretion of Cytosolic Proteins
por: Yamada, Kohji, et al.
Publicado: (2023)

Dual roles of oxostephanine as an Aurora kinase inhibitor and angiogenesis suppressor
por: Tran, Thu-Hien Thi, et al.
Publicado: (2022)

Thymidine phosphorylase mRNA expression may be a predictor of response to post-operative adjuvant chemotherapy with S-1 in patients with stage III colorectal cancer
por: OGAWA, MASAICHI, et al.
Publicado: (2014)

Interaction of Abl Tyrosine Kinases with SOCS3 Impairs Its Suppressor Function in Tumorigenesis()()()
por: Feng, Riyue, et al.
Publicado: (2018)

Targeted polypharmacology: Discovery of dual inhibitors of tyrosine and phosphoinositide kinases
por: Apsel, Beth, et al.
Publicado: (2008)

Abl kinases can function as suppressors of tumor progression and metastasis
por: Marchal, Melissa A., et al.
Publicado: (2023)

Myasthenic Crisis Complicated with Myxedema, Positive for Both Anti-acetylcholine Receptor and Anti-muscle-specific Tyrosine Kinase Antibodies
por: Horiuchi, Kazuhiro, et al.
Publicado: (2017)

AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis
por: Choi, Yun Jung, et al.
Publicado: (2019)

Detection of bacterial DNA from central venous catheter removed from patients by next generation sequencing: a preliminary clinical study
por: Okuda, Ken-ichi, et al.
Publicado: (2018)

Changes in blood pressure during treatment with the tyrosine kinase inhibitor lenvatinib
por: Saito, Kei, et al.
Publicado: (2020)

Resection of liver metastasis from submandibular gland carcinoma five years after the primary operation: A case
por: Nakashima, Keigo, et al.
Publicado: (2021)

Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis
por: Liu, Li-na, et al.
Publicado: (2013)

Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis
por: He, Ying, et al.
Publicado: (2021)

Differential Evolutionary Wiring of the Tyrosine Kinase Btk
por: Nawaz, Hossain M., et al.
Publicado: (2012)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
por: Hempel, Cornelius, et al.
Publicado: (2017)

Phase I safety and pharmacokinetic study of cipatinib, an original dual tyrosine kinase inhibitor
por: Wang, Jiayu, et al.
Publicado: (2018)

A Bioinformatics Evaluation of the Role of Dual-Specificity Tyrosine-Regulated Kinases in Colorectal Cancer
por: Laham, Amina Jamal, et al.
Publicado: (2022)

Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells
por: Takada, Naoki, et al.
Publicado: (2021)

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
por: Amano, Hideki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pnl58krb9vccuq311ugosgqkt5